PharmaCyte Biotech Statistics

Total Valuation

PMCB has a market cap or net worth of $5.84 million. The enterprise value is -$9.70 million.

Market Cap	5.84M
Enterprise Value	-9.70M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

PMCB has 6.87 million shares outstanding. The number of shares has decreased by -23.50% in one year.

Current Share Class	6.87M
Shares Outstanding	6.87M
Shares Change (YoY)	-23.50%
Shares Change (QoQ)	-1.51%
Owned by Insiders (%)	2.85%
Owned by Institutions (%)	10.85%
Float	6.15M

Valuation Ratios

The trailing PE ratio is 0.27.

PE Ratio	0.27
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.11
P/TBV Ratio	0.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.68

Current Ratio	7.68
Quick Ratio	6.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 63.05% and return on invested capital (ROIC) is -5.63%.

Return on Equity (ROE)	63.05%
Return on Assets (ROA)	-4.76%
Return on Invested Capital (ROIC)	-5.63%
Return on Capital Employed (ROCE)	-8.38%
Revenue Per Employee	n/a
Profits Per Employee	$11.68M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.05% in the last 52 weeks. The beta is -0.29, so PMCB's price volatility has been lower than the market average.

Beta (5Y)	-0.29
52-Week Price Change	-54.05%
50-Day Moving Average	1.03
200-Day Moving Average	1.39
Relative Strength Index (RSI)	33.52
Average Volume (20 Days)	37,976

Short Selling Information

The latest short interest is 11,299, so 0.16% of the outstanding shares have been sold short.

Short Interest	11,299
Short Previous Month	10,432
Short % of Shares Out	0.16%
Short % of Float	0.18%
Short Ratio (days to cover)	0.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.38M
Pretax Income	-1.14M
Net Income	23.36M
EBITDA	n/a
EBIT	-4.38M
Earnings Per Share (EPS)	$3.19

Full Income Statement

Balance Sheet

The company has $15.54 million in cash and n/a in debt, giving a net cash position of $15.54 million or $2.26 per share.

Cash & Cash Equivalents	15.54M
Total Debt	n/a
Net Cash	15.54M
Net Cash Per Share	$2.26
Equity (Book Value)	51.89M
Book Value Per Share	7.64
Working Capital	19.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.98M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	23.50%
Shareholder Yield	23.50%
Earnings Yield	400.16%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 12, 2021. It was a reverse split with a ratio of 1:1,499.93.

Last Split Date	Jul 12, 2021
Split Type	Reverse
Split Ratio	1:1,499.93

Scores

Altman Z-Score	n/a
Piotroski F-Score	1